Singapore markets close in 1 hour 6 minutes
Straits Times Index
3,299.51 -14.54 (-0.44%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,265.13 -371.09 (-1.89%) FTSE 100
8,400.81 -23.39 (-0.28%) Bitcoin USD
70,963.47 +4,126.97 (+6.17%) CMC Crypto 200
1,526.99 +38.45 (+2.58%)
Rocket Pharmaceuticals, Inc. (RCKT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 22.62 |
| Open | 22.70 |
| Bid | 22.80 x 100 |
| Ask | 22.87 x 100 |
| Day's range | 22.65 - 23.15 |
| 52-week range | 14.89 - 32.53 |
| Volume | |
| Avg. volume | 695,743 |
| Market cap | 2.073B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
Rocket Pharmaceuticals' (RCKT) first-quarter earnings beat estimates. Devoid of marketed drugs, the company did not report any revenues during the quarter.
- Zacks
Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why
Rocket Pharmaceuticals (RCKT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Insider Monkey
Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
© 2024 Yahoo. All rights reserved.